NANOVI A/S: Financial statements 2017
CVR: 34889031
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
NANOVI A/S (CVR 34889031) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -4,529,851 and a net result of DKK -10,374,041 compared with DKK -6,426,868 the year before. Equity in the 2017 report amounted to DKK -13,790,592.
- Gross Profit
- DKK -4,529,851
- Profit/Loss
- DKK -10,374,041
- Equity
- DKK -13,790,592
- Total Assets
- DKK 3,964,995
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -4.5M | -10.4M | -13.8M | - |
| 2016 | - | -2.4M | -6.4M | -8.4M | - |
| 2015 | - | - | -7.2M | -3.6M | - |
| 2014 | - | -2.7M | -3.2M | 1.5M | - |
| 2013 | - | -1.1M | -1.9M | 2.7M | - |
Official annual report
Keep an eye on NANOVI A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of December 5, 2017, Thomas Lars Andresen has joined the board of directors of NANOVI A/S.
As of December 5, 2017, Jesper Boysen has joined the board of directors of NANOVI A/S.
As of December 5, 2017, Jesper Boysen is registered as adm. dir. of NANOVI A/S.
As of December 5, 2017, Morten Albrechtsen has stepped down as adm. dir. of NANOVI A/S.
As of December 4, 2017, Thomas Lars Andresen has left the board of directors of NANOVI A/S.
As of December 4, 2017, Jesper Boysen has left the board of directors of NANOVI A/S.
NANOVI A/S has published its annual report for 2016. Gross profit came to DKK -2,443,285, and the net result was DKK -6,426,868.
On May 29, 2017, the company changed its name from NANOVI RADIOTHERAPY A/S to NANOVI A/S.
About NANOVI A/S
NANOVI A/S is a Danish company of the type Aktieselskab based in Kongens Lyngby, founded in 2012. The company is registered under the industry Fremstilling af bestrålingsudstyr og elektromedicinsk og elektroterapeutisk udstyr. The company was previously named NANOVI RADIOTHERAPY A/S and NANOVI RADIOTHERAPY ApS. The management consists of Michael Todd Galbus. The board consists of Percy Charwood Tomlinson Jr (chair), Jesper Boysen and Michael Todd Galbus. The company is owned by Sinmed Holding International B.V.. The company has 1 employee (2024). In 2025, the company reported revenue of DKK 90,321 and a net result of DKK -804,274 compared with DKK -612,100 the year before. Equity in the 2025 report amounted to DKK 560,746.